Cargando…
Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
Oral bisphosphonates are the primary medication for osteoporosis, but concerns exist regarding potential bone‐quality changes or low‐energy fractures. This cross‐sectional study used artificial intelligence methods to analyze relationships among bisphosphonate treatment duration, a wide variety of b...
Autores principales: | Malluche, Hartmut H, Chen, Jin, Lima, Florence, Liu, Lucas J, Monier‐Faugere, Marie‐Claude, Pienkowski, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567493/ https://www.ncbi.nlm.nih.gov/pubmed/34761151 http://dx.doi.org/10.1002/jbm4.10549 |
Ejemplares similares
-
Prevalence of low bone formation in untreated patients with osteoporosis
por: Malluche, Hartmut H., et al.
Publicado: (2022) -
FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023) -
FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
por: Lima, Florence, et al.
Publicado: (2014) -
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
por: Fang, Yifu, et al.
Publicado: (2013) -
Diagnosis of low bone mass in CKD-5D patients
por: Blomquist, Gustav A., et al.
Publicado: (2016)